GLP-1s and Nutrient Deficiency: B12, Iron, Vitamin D, and Malnutrition Evidence

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work largely by cutting how much you eat. When intake drops by a third or more and stays there for months, the math on vitamins, minerals, and protein gets tight fast. This guide walks through what the evidence actually shows about nutrient deficiency and malnutrition risk on these drugs, which nutrients are most at stake, how strong the data really is, and what reasonable steps lower the risk.

Why GLP-1 Drugs Raise the Nutrient Question

The mechanism here is simple and not in dispute. GLP-1 receptor agonists slow stomach emptying and turn down appetite signals in the brain. People feel full sooner and eat less. Trials of semaglutide have measured total calorie cuts in the range of 24% to nearly 40% versus placebo, and real-world reductions tend to land somewhere between 16% and 39%.

That's the whole point for weight loss. But food is also how you get vitamins, minerals, and protein. Cut the volume by a third and you cut the raw supply of nutrients by roughly the same amount, unless the food that remains is unusually nutrient-dense. Most people's diets are not.

There's a second, smaller concern. Slowed gastric emptying and reduced stomach acid could in theory blunt absorption of certain nutrients, especially vitamin B12, which depends on a multi-step process in the stomach and small intestine. And many people on GLP-1 drugs also take metformin, which has its own well-documented effect on B12. The overlap matters, and we'll get into it.

There's a third factor that rarely gets mentioned: duration. A two-week calorie cut barely dents your nutrient stores. A year or two of sustained, drug-driven appetite suppression is a different animal. The body holds large reserves of some nutrients, like vitamin B12 in the liver, and tiny reserves of others, like thiamine. The nutrients with small reserves show shortfalls first, which is exactly the pattern the data show.

So the question isn't whether the conditions for deficiency exist. They clearly do. The question is how often deficiency actually shows up, which nutrients, and how bad it gets. That's where you have to read the evidence carefully instead of trusting headlines.

What the Evidence Actually Shows

The honest summary: the data point toward a real and measurable rise in nutritional deficiencies on GLP-1 drugs, but the strongest studies are observational, the deficiency rates depend heavily on how you define "deficiency," and there is no large randomized trial built specifically to answer this question. Treat the findings as a strong signal, not a settled number.

The large claims-data study

The biggest dataset comes from a 2025 retrospective study in Obesity Pillars that looked at de-identified claims for 461,382 adults newly prescribed a GLP-1 drug, none of whom had a prior diagnosis of nutritional deficiency. Within six months, 12.7% had a new nutritional deficiency diagnosis. Within twelve months, that climbed to 22.4%. The deficiencies that stood out at the one-year mark were thiamine (vitamin B1) and vitamin D.

That's a large, real-world signal. But a few caveats keep it honest. This is claims data, so it captures deficiencies that got coded by a doctor, which can rise simply because patients on these drugs see clinicians more often and get tested more. That surveillance effect is real and can inflate the numbers. It can't prove the drug caused the deficiency. And the population was mostly people with diabetes, many of whom take metformin and have other risk factors baked in.

The flip side is that claims data also undercounts. Plenty of deficiencies never get tested, never get coded, and never make it into the record at all. A person who feels tired and never gets bloodwork is invisible in this dataset. So the 22.4% figure could be too high because of surveillance bias, or too low because of undertesting. The truthful read is that it documents a meaningful, rising rate of diagnosed deficiency without nailing the exact true prevalence. Either way, the trend line moves the wrong direction over the first year, and the specific nutrients it flags line up with what you'd predict from eating less.

The dietary-intake studies

Two smaller 2025 studies looked at what GLP-1 users actually eat rather than what gets diagnosed.

A cross-sectional study in Frontiers in Nutrition (69 adults, mostly women, using 3-day food records) found average intake of 1,748 calories a day, which sounds reasonable. The trouble was the nutrient density. Almost everyone fell short of recommended intake for several nutrients: vitamin D (98.6% below), potassium (98.6% below), choline (94.2% below), magnesium (89.9% below), and iron (88.4% below). Calcium ran low too. B vitamins, interestingly, looked adequate across the group in this sample. Protein hit the recommended percentage of calories but came up short when measured against body weight in grams per kilogram.

A secondary cross-sectional analysis in Obesity Pillars used the Healthy Eating Index to score diet quality in the same kind of population. The overall score was 54 out of 100, well below ideal. Protein timing was lopsided, with about 40% of daily protein eaten at dinner and only 19% at breakfast, which works against muscle preservation. Total protein averaged around 85 grams a day.

These intake studies are small and can't be generalized to everyone. But they line up with the claims data and with basic logic: eat less, and unless you eat very deliberately, your nutrient intake slides.

Putting a grade on it

Here's a sober read of where each nutrient stands.

Nutrient	Strength of evidence on GLP-1	What the data show	How concerned to be
Protein / lean mass	Strong	20-30% of weight lost is lean mass in trials; intake often below grams-per-kg needs	High — actively manageable
Vitamin D	Moderate	Top deficiency in claims data; ~99% below recommended intake in food-record study	Moderate-high
Iron	Moderate	~88% below recommended intake in food-record study	Moderate, esp. menstruating women
Thiamine (B1)	Moderate	Stood out in 461,382-patient claims study at 12 months	Moderate
Vitamin B12	Weak-to-moderate, mostly via metformin overlap	No GLP-1-specific depletion trial; risk rises with concurrent metformin	Moderate if on metformin, low otherwise
Calcium, magnesium, potassium	Moderate (intake), weak (clinical harm)	Widespread shortfalls in intake studies	Moderate

The word "deficiency" gets thrown around loosely. Eating below a recommended intake on paper is not the same as having a blood test that shows a true clinical deficiency. The intake studies measure the first; the claims study measures the second. Both matter, but they're different things.

Nutrient by Nutrient

Protein and muscle loss

This is the best-documented and most actionable concern, so it leads. When you lose weight on any method, some of it is lean mass, including muscle. On GLP-1 drugs, trials suggest roughly 20% to 30% of total weight lost comes from lean tissue, with semaglutide data in the higher end of that range and tirzepatide trials showing a somewhat more favorable fat-to-lean ratio.

Some lean-mass loss is expected and even appropriate. When you shrink, the body needs less muscle to carry less weight, so a portion of the loss is a normal adaptation rather than harm. The worry is the part that's avoidable: muscle you lose because you simply aren't eating enough protein or loading your muscles. That avoidable slice is what tips people toward weakness, slower metabolism, and the kind of frailty that matters most for older adults.

Lean mass loss isn't the same as malnutrition, but inadequate protein intake makes it worse, and the intake studies show many users fall short of the protein their body weight calls for. The protein-timing problem compounds it: eating most of your protein at dinner, as the diet-quality study found, gives your muscles less of the steady supply they use to rebuild through the day. The fix is well established: aim for adequate protein (often cited around 1.0 to 1.5 grams per kilogram of body weight, spread across meals rather than dumped at dinner) and add resistance training. That combination protects most of your muscle. For a deeper dive, see our guides on preventing muscle loss on GLP-1 medications and what research actually shows about Ozempic and muscle loss.

Vitamin D

Vitamin D was the single most common deficiency in the large claims study and was the most widely under-consumed nutrient in the food-record study, where 98.6% of participants fell short of the recommended intake. To be fair, vitamin D deficiency is extremely common in the general population too, so GLP-1 use layers onto an existing problem rather than creating it from scratch. Still, lower food intake plus the fact that few foods are naturally rich in vitamin D, mainly fatty fish, egg yolks, and fortified dairy, makes a shortfall likely. There's a second reason to care here: vitamin D works with calcium and protein to support bone, and bone is already a question mark during rapid weight loss. A blood test (25-hydroxyvitamin D) settles the question, and supplementation is cheap and safe within recommended limits. Of all the nutrients on this list, vitamin D is probably the easiest and lowest-risk one to correct.

Iron

Iron intake ran far below recommendations in the food-record study, with roughly 88% of participants under the mark. The clinical risk is highest for menstruating women, who already have higher iron needs and a higher baseline rate of deficiency. Two things make iron easy to miss on a GLP-1 drug. First, red meat is a common food people drop because it sits heavy when gastric emptying is slowed, and red meat is one of the best iron sources. Second, the early symptoms of low iron, fatigue and feeling cold and short of breath on exertion, look a lot like the general drag people sometimes feel on these medications. So iron can hide in plain sight. A ferritin and complete blood count test is the way to check rather than guessing, and ferritin is the more sensitive early marker of the two.

Thiamine (Vitamin B1)

Thiamine showed up as a notable deficiency in the large claims study at the one-year mark. Thiamine stores in the body are small, so a sustained drop in intake depletes them within weeks to months. Severe thiamine deficiency is serious, but it's uncommon; the signal here is a reason to keep intake up and, for some patients, to consider a B-complex, not a reason to panic.

Vitamin B12 — and the metformin overlap

This is the most misunderstood nutrient on the list, so it's worth being precise. There is no GLP-1-specific trial showing that these drugs deplete B12 on their own. In the Frontiers in Nutrition food-record study, B vitamin intake actually looked adequate. The theoretical mechanism, slowed digestion and reduced stomach acid impairing the food-cobalamin step, is plausible but unproven for GLP-1 drugs in isolation.

The real story is metformin. Metformin's effect on B12 is well documented. In the Diabetes Prevention Program Outcomes Study, a long-term randomized trial, combined low and borderline-low B12 was far more common in metformin users than placebo at 5 years (19.1% versus 9.5%). The mechanism is interference with calcium-dependent B12 absorption in the terminal ileum. Across studies, 6% to 30% of long-term metformin users develop low B12.

A 2021 hospital study in Qatar found that GLP-1 users were more likely to be B12-deficient on a simple comparison (12.4% of the deficient group used a GLP-1 versus 6.2% of the normal group). But once the researchers adjusted for other factors, including metformin, GLP-1 use dropped out as an independent risk factor. In plain terms: the association looked like it tracked with metformin and other variables, not the GLP-1 itself.

Bottom line on B12: if you take metformin alongside your GLP-1, B12 monitoring makes sense, and that recommendation predates the GLP-1 era. If you're on a GLP-1 alone with a normal diet, the B12 concern is weaker.

Calcium, magnesium, and potassium

The food-record study found widespread intake shortfalls for these minerals. Low intake on paper is the clear signal; documented clinical harm from these specific minerals on GLP-1 drugs is thinner. They're worth tracking through diet quality and, if intake is poor, addressing through food first.

How GLP-1 Drugs Compare on This Risk

Not all weight-loss approaches carry the same nutrient burden, and it helps to put GLP-1 drugs in context.

Approach	Nutrient-deficiency risk	Why
GLP-1 drugs	Moderate; intake-driven, mostly preventable	Calorie cut reduces nutrient supply; absorption mostly intact
Bariatric surgery	High; lifelong supplementation standard	Anatomy changes cut both intake and absorption
Very-low-calorie diets	Moderate-to-high during the diet	Severe calorie restriction without medical formula coverage
Standard calorie deficit	Lower	Smaller deficits, normal digestion

The comparison with bariatric surgery is instructive. After surgery, lifelong vitamin and mineral supplementation is standard of care because both intake and absorption are permanently altered, the gut anatomy literally changes how nutrients are taken up. With GLP-1 drugs, absorption is largely intact and the deficit is driven by eating less, which means the problem is more preventable through diet and targeted supplements. That's an important distinction: a surgery patient often can't out-eat the absorption problem, while a GLP-1 patient frequently can close the gap by eating more deliberately. Some clinicians now borrow the bariatric playbook of routine monitoring, which is sensible given how widely these drugs are now used and how long people are expected to stay on them.

One more honest point on the evidence as a whole. Almost everything we know about GLP-1 nutrient risk comes from observational studies, dietary surveys, and reasoning from mechanism, not from large randomized trials designed to measure deficiency as their main outcome. That's a real limitation. Observational data can show that deficiencies and low intake travel alongside GLP-1 use; they can't cleanly prove cause and effect or hand you a precise risk number. A randomized trial of multivitamin supplementation in GLP-1 users is in progress, which should sharpen the picture. Until then, the responsible stance is to treat the risk as real and worth managing, without inflating it into a scare.

Within the GLP-1 class, the nutrient question is broadly similar across semaglutide and tirzepatide because the appetite-suppression mechanism is shared. Tirzepatide's body-composition data look slightly more favorable for preserving lean mass, but that doesn't change the basic advice on protein and monitoring.

Who Should Pay the Most Attention

The risk is not evenly spread. A few groups deserve closer monitoring:

People also taking metformin (B12), or a proton-pump inhibitor or H2 blocker, which further reduce stomach acid
Menstruating women (iron) and anyone with a history of anemia
Older adults, who absorb B12 less efficiently and lose muscle faster
People with very low calorie intake or strong, persistent appetite suppression
Anyone with restrictive eating patterns, vegetarian or vegan diets without planning, or a prior eating disorder
People who've had bariatric surgery and are now also on a GLP-1

If you're in one of these groups, ask your prescriber about baseline and periodic lab work rather than waiting for symptoms.

Practical Steps That Lower the Risk

None of this requires heroics. The evidence points to a few high-yield moves:

Prioritize protein at every meal. Spread it out instead of loading dinner. This protects muscle, the best-documented concern.
Make calories count. When you're eating less, every bite should carry more nutrients: lean proteins, vegetables, fruit, dairy or fortified alternatives, legumes.
Get baseline labs and recheck. Reasonable targets include vitamin D (25-OH), ferritin and CBC for iron, and B12 if you take metformin or a PPI.
Consider a standard multivitamin if your intake is poor, and discuss targeted supplements (vitamin D, iron, B12) with your clinician based on labs, not guesswork. A randomized trial of multivitamin supplementation in GLP-1 users is underway, so guidance here is still maturing.
Add resistance training to protect muscle alongside adequate protein.
Don't self-diagnose from symptoms alone. Fatigue, hair changes, and brittle nails overlap across many deficiencies and with the drug's own side effects. Labs settle it.

For meal planning specifics, our guide on the best diet to avoid malnutrition on Zepbound goes deeper, and the complete GLP-1 side effects guide covers the broader picture. If bone health is on your mind, see GLP-1 and bone density and fracture risk.

Frequently Asked Questions

Do GLP-1 drugs directly cause vitamin deficiency?

Not directly in most cases. The dominant mechanism is eating less, which lowers nutrient intake. A large claims study found new nutritional deficiencies in 22.4% of users within a year, with vitamin D and thiamine standing out, but observational data can't fully separate the drug's effect from the simple fact of reduced eating. The good news is that an intake-driven shortfall is largely preventable with better food choices and, when needed, supplements.

Should I take a multivitamin while on Ozempic or Zepbound?

It's a reasonable, low-risk step if your food intake is low or your diet quality is poor, and many clinicians suggest a standard multivitamin for that reason. It isn't a substitute for protein or for checking specific nutrients with labs. A randomized trial testing multivitamins in GLP-1 users is in progress, so firmer guidance is coming. Talk to your prescriber about whether a multivitamin plus any targeted supplements makes sense for you.

Do I need B12 monitoring on a GLP-1 drug?

It depends on what else you take. There's no strong evidence that a GLP-1 drug alone depletes B12. But if you also take metformin, B12 monitoring is sensible because metformin is well documented to lower B12 over time. Proton-pump inhibitors and H2 blockers add to the risk. A blood test is the only reliable way to know.

How much protein should I eat to avoid muscle loss?

Many clinicians target roughly 1.0 to 1.5 grams of protein per kilogram of body weight per day, spread across meals rather than concentrated at dinner. Pairing that with resistance training protects most of your muscle. Intake studies show many GLP-1 users fall short of their grams-per-kilogram needs even when protein looks fine as a percentage of calories, so it's worth tracking deliberately.

Are these deficiencies dangerous or mostly minor?

Most are manageable and reversible when caught. The concern isn't a sudden crisis; it's a slow slide over months that can lead to fatigue, muscle loss, anemia, or low vitamin D if nobody is watching. The two best defenses are nutrient-dense eating with enough protein and periodic lab checks for at-risk people. Severe malnutrition is uncommon with attention to diet, but ignoring the issue for a year or more is where problems build.

This article is for general information and is not medical advice. Talk with your doctor or a registered dietitian about your medications, lab work, and supplement decisions.